Cartalax

Cartalax is a synthetic tripeptide consisting of alanine, glutamic acid, and aspartic acid. It is provided in lyophilized powder form to ensure stability and high purity for laboratory research. Cartalax is designed exclusively for in-vitro studies carried out by qualified professionals exploring peptide signaling and regulation.

Research Applications:

Cartalax is used in controlled research protocols addressing topics such as:

• Controlled investigation of short regulatory peptides in vitro
• Structure–function studies of AED tripeptides under laboratory conditions
• Research into peptide stability and solubility profiles
• Comparative testing of thymic- and cartilage-related peptide analogues

Storage and Handling:

• Store lyophilized powder at −20 °C until use
• Once reconstituted, store at 2–8 °C and use promptly
• Apply aseptic technique during handling

Product Specifications:

• Purity: ≥99% (HPLC Certified)
• Appearance: Lyophilized white to off-white powder
• Solubility: Soluble in bacteriostatic water

Compliance Notice:

Cartalax is FOR RESEARCH USE ONLY. It is not intended for human or veterinary use. This product has not been evaluated by the FDA. Misuse may violate federal, state, or local laws. By purchasing this product, the buyer represents and warrants that it will be used only for in vitro research purposes.